Status: Recruiting
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
A Phase I clinical trial of the safety and tolerability of tumor-associated lymph node T cell injection in patients with advanced malignant solid tumors, including but not limited to melanoma, head and neck tumors, cervical cancer, and non-small cell lung cancer.
Participants needed: 32
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Guangzhou FineImmune Biotechnology Co., LTD.Updated: Mar 26, 2025Locations: 1
Eligibility criteria
Sign a written informed consent (ICF) and be able to comply with the visit and r... [+8]
meningeal metastases, and/or active brain metastases; [+19]